Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
74
-
Total shares
-
27.9M
-
Shares change
-
+5.94M
-
Total reported value, excl. options
-
$74.5M
-
Value change
-
+$15.5M
-
Put/Call ratio
-
1.42
-
Number of buys
-
39
-
Number of sells
-
-21
-
Price
-
$2.67
Significant Holders of SORRENTO THERAPEUTICS INC - Common Stock (SRNE) as of Q2 2019
78 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - Common Stock as of Q2 2019.
SORRENTO THERAPEUTICS INC - Common Stock (SRNE) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.9M shares
.
Largest 10 shareholders include BlackRock Inc. (7.81M shares), VANGUARD GROUP INC (4.8M shares), STATE STREET CORP (2.27M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.09M shares), GEODE CAPITAL MANAGEMENT, LLC (1.46M shares), CVI Holdings, LLC (1.4M shares), NORTHERN TRUST CORP (1.35M shares), Hudson Bay Capital Management LP (662K shares), Bank of New York Mellon Corp (453K shares), and NUVEEN ASSET MANAGEMENT, LLC (449K shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.